Ad
related to: printable customer call list dataset 1 6 16 2
Search results
Results From The WOW.Com Content Network
"The Taskmaster corpus consists of THREE datasets, Taskmaster-1 (TM-1), Taskmaster-2 (TM-2), and Taskmaster-3 (TM-3), comprising over 55,000 spoken and written task-oriented dialogs in over a dozen domains." [338] Taskmaster-1: goal-oriented conversational dataset. It includes 13,215 task-based dialogs comprising six domains.
Amazon Web Services began hosting Common Crawl's archive through its Public Data Sets program in 2012. [9]The organization began releasing metadata files and the text output of the crawlers alongside .arc files in July 2012. [10]
Dataset name Brief description Preprocessing Instances Format Default task Created (updated) Reference Creator Aff-Wild 298 videos of 200 individuals, ~1,250,000 manually annotated images: annotated in terms of dimensional affect (valence-arousal); in-the-wild setting; color database; various resolutions (average = 640x360)
A call detail record (CDR) is a data record produced by a telephone exchange or other telecommunications equipment that documents the details of a telephone call or other telecommunications transactions (e.g., text message) that passes through that facility or device. The record contains various attributes of the call, such as time, duration ...
Throughout the process, if the customer wants to talk to an agent, they simply opt out of the support, provide a phone number, and almost instantly the phone rings (amazing fast most of the time ...
Reference data sets are sometimes alternatively referred to as a "controlled vocabulary" [2] or "lookup" data. [3] Reference data differs from master data. While both provide context for business transactions, reference data is concerned with classification and categorisation, while master data is concerned with business entities. [4]
As a reminder, we set a long-term target of 20% ARR contribution margins by 2027 at our Investor Day in March 2023 and ended 2024 at 16.6%, so we are well ahead of that plan.
Sales of our biosimilar products were $2.2 billion in 2024, an increase of 16% year over year. In the fourth quarter, our team readily executed the launch of PAVBLU, a biosimilar to EYLEA, with ...